Details for New Drug Application (NDA): 019574

✉ Email this page to a colleague

NDA 019574 describes THALITONE, which is a drug marketed by Casper Pharma Llc and Monarch Pharms and is included in two NDAs. It is available from one supplier. Additional details are available on the THALITONE profile page.

The generic ingredient in THALITONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.

Summary for 019574

Tradename:	THALITONE
Applicant:	Casper Pharma Llc
Ingredient:	chlorthalidone
Patents:	0

Pharmacology for NDA: 019574

Physiological Effect	Increased Diuresis

Medical Subject Heading (MeSH) Categories for 019574

Antihypertensive Agents
Diuretics
Sodium Chloride Symporter Inhibitors

Suppliers and Packaging for NDA: 019574

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
THALITONE	chlorthalidone	TABLET;ORAL	019574	NDA	Casper Pharma LLC	70199-001	70199-001-01	100 TABLET in 1 BOTTLE (70199-001-01)
THALITONE	chlorthalidone	TABLET;ORAL	019574	NDA	Casper Pharma LLC	70199-001	70199-001-30	30 TABLET in 1 BOTTLE (70199-001-30)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Dec 20, 1988	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	25MG
Approval Date:	Feb 12, 1992	TE:	BX	RLD:	Yes

Expired US Patents for NDA 019574

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Casper Pharma Llc	THALITONE	chlorthalidone	TABLET;ORAL	019574-001	Dec 20, 1988	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.